Syntekabio

BiopharmaTrend.com

BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Syntekabio

Syntekabio logo

Founded
2009

Patents
10

Publications
11

Technologies

AI Companies (Drug Discovery)

Syntekabio is a leading AI-driven drug discovery company that uses machine learning and supercomputing to discover new drugs.

personal genome map genome-based disease

Interviews

Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung

R&D Platform

We address the entire spectrum of drug development. We use the cutting-edge computational biology technologies for novel drug candidate discovery. We also specialize in co-developing novel drug response biomarkers of the existing drug candidates, which allows improvement of likelihood of successful clinical trial, biomarker-driven indication expansion, and enhanced understanding of the drug's mechanism of action.

This company appears in our reports:

AI Companies (Drug Discovery)